Patents by Inventor Yoshiko Kashiwagi

Yoshiko Kashiwagi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090068744
    Abstract: The present invention provides a vitreous cell line capable of expressing an exogenous immortalizing gene, and a production method thereof. Since the vitreous cell line of the present invention can produce a sufficient number of cells and has constant and continuous proliferative capacity, it can be advantageously utilized for the elucidation of the pathogenesis of retinal vitreous diseases, and the development of a drug for the prophylaxis and/or treatment of retinal vitreous diseases. Moreover, the cell line is not only highly useful for the biochemical-physiological studies of the vitreous body, and further for the study of cell differentiation mechanisms, but also possibly usable as a biological material of an artificial vitreous body.
    Type: Application
    Filed: February 13, 2007
    Publication date: March 12, 2009
    Applicants: SENJU PHARMACEUTICAL CO., LTD.
    Inventors: Hidetoshi Yamashita, Teiko Yamamoto, Kouichi Nishitsuka, Yoshiko Kashiwagi, Naoki Tojo
  • Publication number: 20090053812
    Abstract: The present invention provides a scleral cell strain capable of expressing an exogenous immortalizing gene, and a production method thereof. Since the scleral cell strain of the present invention can produce a sufficient number of cells and has constant and continuous proliferative capacity, it can be advantageously utilized for the elucidation of the pathogenesis of ophthalmic diseases such as scleral inflammation, and the development of a drug for the prophylaxis and/or treatment of said diseases. Moreover, the cell strain is not only highly useful for the biochemical-physiological studies of the sclera, and further for the study of cell differentiation mechanisms, but also possibly usable as a biological material of an artificial sclera.
    Type: Application
    Filed: February 13, 2007
    Publication date: February 26, 2009
    Applicants: SENJU PHARMACEUTICAL CO., LTD.
    Inventors: Hidetoshi Yamashita, Teiko Yamamoto, Yoshiko Kashiwagi